Aromatase Inhibitor Drugs

Focus Your Research

Click any topic below to filter + focus research

36 Diseases Researched for Aromatase Inhibitor Drugs

Name	AC	CK
Breast Cancer	12	174
Drug-Induced Toxicity	8	124
Musculoskeletal Abnormalities	4	90
Arthralgia	2	40
Arthritis	1	30
Breast Cancer: Recovery	1	30
Myalgias	1	30
Osteoporosis	1	30
Polymyalgia Rheumatica	1	30
Tendinitis	1	30
Musculoskeletal Complaints	2	21
Vitamin D Deficiency	2	21
Bone Diseases	1	20
Bone Fractures	1	20
Breast Cancer: Male	1	20
Children: Impaired Growth	1	20
Hot Flash	1	20
Insulin-like Growth Factor (IGF): Elevated	1	20
Pain: Musculoskeletal	1	20
Prostatic Hyperplasia: Benign	1	20
Pulmonary Embolism	1	20
Skin Diseases	1	20
Cognitive Decline/Dysfunction	1	10
Glomerulonephritis	1	10
HPA Axis Dysregulation	1	10
Rheumatic Diseases	1	10
Birth Defects	2	4
Ovarian Diseases	1	4
Polycystic Ovary Syndrome	2	4
Prenatal Chemical Exposures	2	4
Abortion: Spontaneous	1	2
Breast Cancer: Prevention	1	2
Cachexia: Cancer	1	1
Cancers: All	1	1
Colon Cancer	1	1
Drug-Induced Toxicity: Aromatase Inhibitors	1	1

6 Adverse Pharmacological Actions Researched for Aromatase Inhibitor Drugs

Name	AC	CK
Carcinogenic	1	20
Endocrine Disruptor	1	20
Endocrine Disruptor: Pituitary	1	10
Embryotoxic	2	4
Teratogenic	2	4
Neurotoxic	1	2

Research Articles 25
Cumulative Knowledge Score 40
Overall Research Rating GOOD

View the Evidence:
25 Abstracts with Aromatase Inhibitor Drugs Research

Filter by Study Type

Sort Abstracts

Limited to Members Only

By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process.

Currently Available Sorting Options

Article Published Date - Sort all displayed articles by their published date
Quick Summary Fieldsets - Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge - Default sorting method. Allows you to sort descendingly

Free Sample of Member-Only Features

Although all 30,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 10000 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Friend membership gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to order a membership

[+]

Aromatase Inhibitor Drugs jQuery(function ($) { $(".node-field-image").click(function () { $(".node-field-image").toggleClass("open"); }); $(".node.topic>.colfull").click(function () { $(".node.topic>.colfull").toggleClass("open"); }); })

Focus Your Research

Click any topic below to filter + focus research

The Following are Sub-Topics of Aromatase Inhibitor Drugs

View the Evidence: 25 Abstracts with Aromatase Inhibitor Drugs Research

Limited to Members Only

Currently Available Sorting Options

Two year treatment with Tamoxifen and Arimidex result in a number of side effects which reduce quality of life. Dec 01, 2006

A case of anastrozole-induced pulmonary emboli has been reported.Oct 01, 2006

Adjuvant treatment with aromatase inhibitors in breast cancer result in higher rates of hot flushes, musculoskeletal complaints, osteoporosis and fractures.Aug 01, 2006

Anastrozole has been reported to cause skin eruptions as a potential side effects. Jan 01, 2009

Anastrozole use has been associated with sclerosing glomerulonephritis in a patient with breast cancer.Jan 01, 2007

Arimidex (anastrozole) treatment in men with breast cancer is associated with toxicity in 37.5% of the group studied.Oct 01, 2010

Arimidex therapy contributes in the decline of bone mineral density in early breast cancer patients.Jan 01, 2010

Aromatase inhibitors can induce an arthralgia syndrome.Jul 01, 2008

Clinically relevant musculoskeletal symptoms develop in women treated with aromatase inhibitors, leading to treatment discontinuation in a substantial percentage of these patients.Sep 15, 2010

Letrozole decreases estrogen levels at 12 months but not 24 months, reduces bone density, does not reduce mammographic breast density at 12 months and increases IGF-1 (a known carcinogen) at 12 and 24 months in Apr 01, 2010

Musculoskeletal complaints are exceedingly common (71.5%) in those receiving long-term (6 months or longer) aromatase inhibitor therapy.Feb 01, 2010

Musculoskeletal pains in breast cancer patients under third generation AIs can be severe, debilitating and are associated with tenosynovial and joint changes.Jul 01, 2007

Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia.Oct 01, 2010

Tamoxifen and Arimidex (anastrozole) can have detrimental effects on higher brain functions.Mar 24, 2010

The aromatase inhibitor letrozole has endocrine disruptive properties on hypothalamic-pituitary output in normal women.Feb 24, 2011

The aromatase inhibitors anastrozole, letrozole and exemestane have been associated with skeletal complications, arthralgia, mucuoskeletal pain and sexual dysfunction.Feb 01, 2008

Treatment with Arimidex, a known osteopenic agent, is associated with a high prevalence of commonly unrecognized vitmain D deficiency in women with early breast cancer.Apr 14, 2010

Arimidex has been demonstrated to cause ovarian damage in animals.Jan 01, 2009

Gestational exposure to doses of letrozole that are equal to or lower than the daily recommended human dose has toxic effects on prenatal development in rats.Aug 01, 2008

Letrozole has a toxic effect on the embryos of rats. Nov 01, 2009

Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome.May 09, 2023

Ocimum kilimandscharicum L. restores ovarian functions in letrozole-induced polycystic ovary syndrome.Jul 07, 2019

The cognitive deficits observed in postmenopausal women treated with aromatase inhibitors may be due to their adverse effect on hippocampal function.Mar 01, 2010

Acupuncture is safe and results in improvement in AIMSS symptoms, but similar benefits are also elicited by non-penetrating sham acupuncture.Mar 01, 2015

Vitamin D status should be monitored in all cancer patients and treated by adequate vitamin D3 supplementation. Nov 30, 2015

Print Options

Aromatase Inhibitor Drugs

View the Evidence:
25 Abstracts with Aromatase Inhibitor Drugs Research